Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Enhancement of lymphokine-activated killer cell induction using anti-CD25 and anti-CTLA-4 monoclonal antibodies.

Oncology reports - 1 Jun 2007

Okita Riki, Yamaguchi Yoshiyuki, Emi Akiko, Matsuura Kazuo, Toge Tetsuya

Abstract excerpt

Immunosuppression may contribute to cancer progression, in which regulatory T (T-reg) cells have been demonstrated to play important roles. We investigated whether anti-CD25 (alpha-CD25) monoclonal antibody (mAb) and anti-cytotoxic T lymphocyte-associated antigen-4 (alpha-CTLA-4) mAb could augment in vitro proliferation and cytotoxic activity against cancer cell lines of lymphokine-activated killer (LAK) cells....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD
Share to Antigens, Differentiation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CTLA-4 Antigen

Share to Cytotoxicity, Immunologic

Share to Interferon-gamma

Share to Interleukin-2 Receptor alpha Subunit

Share to Killer Cells, Lymphokine-Activated

Share to Lymphocyte Activation

Source

Identifiers

PMID: 17487401

Genes

FOXP3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Enhancement of lymphokine-activated killer cell induction using anti-CD25 and anti-CTLA-4 monoclonal antibodies.PMID 17487401Read ↗

Gemcitabine treatment enhanced the anti-tumor effect of cytokine induced killer cells by depletion of CD4+CD25bri regulatory T cells.Semantic proximity Read ↗

CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression.Semantic proximity Read ↗

CD4+CD25high regulatory cells in peripheral blood of cancer patients.Semantic proximity Read ↗

CD4 +CD25 + regulatory T cells decreased the antitumor activity of cytokine-induced killer (CIK) cells of lung cancer patients.Semantic proximity Read ↗

CD4+CD25+ regulatory T cells in the peripheral blood of patients with breast cancer and non-small cell lung cancer.Semantic proximity Read ↗

T regulatory cells control T‐cell proliferation partly by the release of soluble CD25 in patients with B‐cell malignanciesSemantic proximity Read ↗

CD25+ CD4+ regulatory T-cells in cancer.Semantic proximity Read ↗

Phenotypic analysis of tumor-infiltrating lymphocytes in hepatocellular carcinoma.Semantic proximity Read ↗

CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2.Semantic proximity Read ↗

Regulatory T-cells in antitumor therapy: isolation and functional testing of CD4+CD25+ regulatory T-cells.Semantic proximity Read ↗

Characterization of rabbit antithymocyte globulins-induced CD25+ regulatory T cells from cells of patients with end-stage renal disease.Semantic proximity Read ↗

Gamma irradiation alters the phenotype and function of CD4+CD25+ regulatory T cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.